Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

MTLS vs ALTS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ALTS Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 5–5 Matrix Metrics)

ALTS Overall Winner 6-Pillar Tally: MTLS 3 – 3 ALTS Matrix Metrics: MTLS 5 – 5 ALTS

As of Nov 17, 2026, ALT5 Sigma Corporation (ALTS) is the stronger overall head-to-head candidate over Materialise NV (MTLS) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). MTLS carries a Unified Composite Score of 53.5/100 (HOLD) at $6.28 (N/M Forward P/E, 3.4% operating margin), whereas ALTS carries 57.2/100 (HOLD) at $0.85 (4.8x Forward P/E, -48.1% operating margin).

  • Technical & Structure Timing Caution: MTLS trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 31.4); meanwhile ALTS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About MTLS vs ALTS
MTLS NASDAQ
Materialise NV
Services-Prepackaged Software
$6.28
+1.13% 1D
Market Cap $369.9M
TTM Revenue $605M
Forward P/E N/M
Beta / 30D Vol 1.10β · 88% Vol
Unified Composite Score
53.5 / 100 HOLD
Tech 53.0 Fund 53.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 31
RSI-14: 31.4 · SMA20: $7.28 · SMA50: $7.78
ALTS NASDAQ Head-to-Head Winner
ALT5 Sigma Corporation Common Stock
Pharmaceutical Preparations
$0.85
+0.59% 1D
Market Cap $118.9M
TTM Revenue $25M
Forward P/E 4.8x
Beta / 30D Vol 3.07β · 83% Vol
Unified Composite Score
57.2 / 100 HOLD
Tech 45.0 Fund 59.0 Flow 67.0 Mom 68.2
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -24.5%), weak momentum, RSI 33
RSI-14: 33.3 · SMA20: $0.98 · SMA50: $1.22

6-Pillar Scorecard Institutional Category Breakdown (MTLS 3 – 3 ALTS)

Columns: Metric · MTLS · ALTS
1. Valuation Multiples ALTS
Forward P/E N/M 4.8x
Trailing P/E 25.0x 4.8x
PEG Ratio 1.26x 0.97x
EV / Revenue 0.6x 5.5x
2. Growth & Scale ALTS
Revenue Growth (YoY) +2.1% +12.5%
Earnings Growth (YoY) -33.3% +118.7%
TTM Revenue (USD) $605M $25M
Market Cap $369.9M $118.9M
3. Profitability & Quality MTLS
Gross Margin 57.4% 41.0%
Operating Margin 3.4% -48.1%
Net Profit Margin 4.6% 0.0%
Return on Equity (ROE) 5.0% -57.9%
4. Balance Sheet & Cash Flow MTLS
Cash Generation (TTM) $55M EBITDA -$20M EBITDA
Cash Flow Margin 9.1% EBITDA Mgn -78.6% EBITDA Mgn
Net Cash / Leverage $4.97 Book/Sh · 5.0% ROE $18M Net Debt (0.03x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ALTS
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 127.1% (26th %ile)
Put/Call OI Skew Thin ADR Chain 0.41x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat MTLS
OpEx & R&D Intensity 54.0% of Rev ($327M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Software - Application Operator Software - Application Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: MTLS (5) vs ALTS (5)
Institutional Metric MTLS ALTS Criterion Row Edge
Market Capitalization
Scale
$369.9M $118.9M Larger Scale MTLS
Trailing P/E Ratio
Valuation
25.0x 4.8x Lower Multiple ALTS
Forward P/E Ratio
Valuation
N/M 4.8x Lower Multiple ALTS
Revenue Growth (YoY)
Growth
+2.1% +12.5% Higher Growth ALTS
Operating Margin (TTM)
Profitability
3.4% -48.1% Higher Margin MTLS
Net Profit Margin
Profitability
4.6% 0.0% Higher Margin MTLS
Return on Equity (ROE)
Capital Efficiency
5.0% -57.9% Higher ROE MTLS
52-Week Range Position
Momentum
37% ($5–$9) 0% ($1–$11) Stronger Trend MTLS
Beta / 30D Volatility
Risk Regime
1.10β · 88% Vol 3.07β · 83% Vol Lower Realized Risk ALTS
Unified Institutional Score
Composite Signal
53.5 / 100 (HOLD) 57.2 / 100 (HOLD) Higher Composite ALTS
Trailing 12M Revenue (USD)
Operating Scale
$605M $25M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
57.4% 41.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.26x PEG · 0.6x EV/Rev 0.97x PEG · 5.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$55M EBITDA ($4.97 Book/Sh · 5.0% ROE) -$20M EBITDA ($18M Net Debt (0.03x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon MTLS +40.91 pp
MTLS: +10.42% · ALTS: -30.49%
3M Horizon MTLS +53.54 pp
MTLS: -7.42% · ALTS: -60.96%
6M Horizon MTLS +42.95 pp
MTLS: -11.81% · ALTS: -54.76%
1Y Horizon MTLS +42.95 pp
MTLS: -11.81% · ALTS: -54.76%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MTLS vs ALTS. Trailing 12-month operating profitability (MTLS 3.4% vs ALTS -48.1%) and valuation multiples (MTLS N/M vs ALTS 4.8x Forward P/E) are benchmarked directly in Pillar 4 below.

MTLS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$605M
Gross Margin57.4%
Op. Margin3.4%
ROE / Fwd P/E5.0% · N/M
ALTS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$25M
Gross Margin41.0%
Op. Margin-48.1%
ROE / Fwd P/E-57.9% · 4.8x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
MTLS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew Thin ADR Chain
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MTLS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ALTS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 127.1%
IV Percentile 26th %ile
Put/Call OI Skew 0.41x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ALTS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
MTLS Moat Profile Cyclical / Execution-Driven Positioning
Software - Application Operator
Competes within the Software - Application value chain with $369.9M market capitalization and 3.4% operating margin.
OpEx & R&D Reinvestment 54.0% of Rev ($327M)
90D Engineering Disclosures 0 Published
ALTS Moat Profile Cyclical / Execution-Driven Positioning
Software - Application Operator
Competes within the Software - Application value chain with $118.9M market capitalization and -48.1% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ MTLS vs ALTS Key Questions & Quantitative Answers

As of Nov 17, 2026, ALT5 Sigma Corporation (ALTS) is the stronger overall head-to-head candidate over Materialise NV (MTLS) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). MTLS carries a Unified Composite Score of 53.5/100 (HOLD) at $6.28 (N/M Forward P/E, 3.4% operating margin), whereas ALTS carries 57.2/100 (HOLD) at $0.85 (4.8x Forward P/E, -48.1% operating margin). Technical & Structure Timing Caution: MTLS trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 31.4); meanwhile ALTS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ALTS leads the Growth & Scale pillar: MTLS posts +2.1% YoY revenue growth and -33.3% YoY earnings growth on $605M TTM revenue (57.4% gross margin, 3.4% operating margin), compared with ALTS at +12.5% YoY revenue growth and +118.7% YoY earnings growth on $25M TTM revenue (41.0% gross margin, -48.1% operating margin). On trailing 12-month operating scale, MTLS generates $605M in USD-normalized revenue versus $25M for ALTS. In operating R&D and SG&A reinvestment, MTLS deploys 54.0% of Rev ($327M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ALTS.

ALTS screens cheaper on headline valuation multiples. MTLS trades at N/M Forward P/E, 25.0x Trailing P/E, 1.26x PEG, and 0.6x EV/Revenue (9.1% EBITDA margin), whereas ALTS trades at 4.8x Forward P/E, 4.8x Trailing P/E, 0.97x PEG, and 5.5x EV/Revenue (-78.6% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MTLS (5.0% ROE) versus ALTS (-57.9% ROE) capital efficiency.

In options market volatility and institutional positioning, MTLS carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.10β · 88% Vol realized risk). By comparison, ALTS carries 127.1% implied volatility (26th %ile, Balanced (25th–60th %ile)), a 0.41x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (3.07β · 83% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.